AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27147450 — intervention group
Group type: COMPARATOR
Intervention: Usual Outpatient Family Support (UOFS)
Number of subjects: 116
Study 25636180 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress management program (four 30-minute individual sessions)
Number of subjects: 120
Study 25636180 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (1,200 mg/day of eicosapentaenoic acid and 600 mg/day of docosahexaenoic acid for 90 days)
Number of subjects: 120
Study 25636180 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress management program
Number of subjects: 120
Study 25636180 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 120
Study 25636180 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation using a leaflet (control group)
Number of subjects: 120
Study 23201326 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone (2.5mg daily)
Number of subjects: 174
Study 23201326 — intervention group
Group type: EXPERIMENTAL
Intervention: E2/NETA (1mg oestradiol + 0.5mg norethindrone acetate)
Number of subjects: 174
Study 23201326 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate + Vitamin D3 (50mg + 200 IU)
Number of subjects: 174
Study 20568387 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy (SCIT) injections
Number of subjects: 1922
Study 20568387 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 1922
Study 18586644 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish sauce containing 10 mg of iron (either as NaFe‐EDTA or FeSO4+citrate)
Number of subjects: 140
Study 18586644 — intervention group
Group type: COMPARATOR
Intervention: Placebo Khmer fish sauce
Number of subjects: 140
Study 18586644 — intervention group
Group type: EXPERIMENTAL
Intervention: FeSO4+citrate
Number of subjects: 140
Study 18586644 — intervention group
Group type: EXPERIMENTAL
Intervention: NaFe‐EDTA
Number of subjects: 140
Study 16539556 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-bonded group (group 1) using light-cured adhesive and primer (Transbond XT)
Number of subjects: 60
Study 16539556 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect-bonded group (group 2) using chemical-cured primer (Sondhi Rapid Set) and light-cured adhesive (Transbond XT)
Number of subjects: 60
Study 16539556 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect-bonded group (group 3) using light-cured primer (Orthosolo) and adhesive (Enlight LV)
Number of subjects: 60
Study 12668405 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) plus treatment as usual (TAU)
Number of subjects: 66
Study 12668405 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) and supportive psychotherapy (SPT) combined
Number of subjects: 66
Study 12668405 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 66
Study 12668405 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive psychotherapy (SPT)
Number of subjects: 66
Study 12668405 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 66
Study 11079667 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-awareness training followed by exercise training (Group A)
Number of subjects: 26
Study 11079667 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training only (Group B)
Number of subjects: 26
Study 11079667 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 26
Study 9187164 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic nebulizer (UN)
Number of subjects: 113
Study 9187164 — intervention group
Group type: COMPARATOR
Intervention: Jet nebulizer (JN)
Number of subjects: 113
Study 1526089 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg nizatidine twice daily
Number of subjects: 456
Study 1526089 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg nizatidine at bedtime
Number of subjects: 456
Study 1526089 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 456
Study 1526089 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine (both doses)
Number of subjects: 456
Study 3094360 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil diet
Number of subjects: 23
Study 3094360 — intervention group
Group type: COMPARATOR
Intervention: Corn oil diet
Number of subjects: 23
Study 29750261 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential intensity-modulated radiation therapy
Number of subjects: 178
Study 27912947 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong/Tai Chi Easy (QG/TCE)
Number of subjects: 87
Study 27912947 — intervention group
Group type: COMPARATOR
Intervention: Sham Qigong (SQG)
Number of subjects: 87
Study 24906029 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan (15 mg/day, titrated to 30 mg/day and 60 mg/day)
Number of subjects: 37
Study 24906029 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 22502793 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular hyaluronic acid (HA) injections plus physical therapy (PT)
Number of subjects: 70
Study 22502793 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (PT) alone
Number of subjects: 70
Study 20412150 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild sedation with midazolam (score of 3)
Number of subjects: 12
Study 20412150 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep sedation with midazolam (score of 1)
Number of subjects: 12
Study 18614875 — intervention group
Group type: EXPERIMENTAL
Intervention: Low serum alpha-fetoprotein level (<5.0 ng/ml)
Number of subjects: 383
Study 15631865 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH-a plus tibolone
Number of subjects: 70
Study 15631865 — intervention group
Group type: COMPARATOR
Intervention: GnRH-a alone
Number of subjects: 70
Study 15631865 — intervention group
Group type: COMPARATOR
Intervention: Untreated patients (control group)
Number of subjects: 70
Study 11823400 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal anesthesia
Number of subjects: 50
Study 11823400 — intervention group
Group type: COMPARATOR
Intervention: No caudal anesthesia (Control)
Number of subjects: 50
Study 9878016 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant gp160 immunization every 2 months for 5 years
Number of subjects: 0
Study 9878016 — intervention group
Group type: COMPARATOR
Intervention: Placebo every 2 months for 5 years
Number of subjects: 0
Study 9878016 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant gp160 immunization
Number of subjects: 0
Study 7719750 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender oil (6 drops added to bath water daily for 10 days)
Number of subjects: 0
Study 7719750 — intervention group
Group type: COMPARATOR
Intervention: Control (no lavender oil)
Number of subjects: 0
Study 2189075 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril, 10-20 mg
Number of subjects: 12
Study 2189075 — intervention group
Group type: COMPARATOR
Intervention: Captopril, 50-100 mg
Number of subjects: 12
Study 6988034 — intervention group
Group type: EXPERIMENTAL
Intervention: Midline incision
Number of subjects: 579
Study 6988034 — intervention group
Group type: COMPARATOR
Intervention: Transverse/oblique muscle-cutting incision
Number of subjects: 579
Study 27324141 — intervention group
Group type: EXPERIMENTAL
Intervention: Flatbreads with 6 g GG, 4 g KM, and 15 g CPF plus 2 or 4 g GG
Number of subjects: 38
Study 27324141 — intervention group
Group type: COMPARATOR
Intervention: Control commercial high-fibre flatbread flour mix (atta)
Number of subjects: 38
Study 26206423 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea extract (843.0 +/- 44.0 mg/day epigallocatechin gallate)
Number of subjects: 1075
Study 26206423 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 1075
Study 23590801 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide pulses plus corticosteroids (6 or 12 pulses)
Number of subjects: 118
Study 23590801 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids alone (for FFS = 0)
Number of subjects: 118
Study 23590801 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (with immunosuppressant adjunct when corticosteroids failed)
Number of subjects: 118
Study 23590801 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 118
Study 23590801 — intervention group
Group type: EXPERIMENTAL
Intervention: Age ≥65 years
Number of subjects: 118
Study 23590801 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-myeloperoxidase antibodies
Number of subjects: 118
Study 23590801 — intervention group
Group type: EXPERIMENTAL
Intervention: Eosinophils >3000/mm(3)
Number of subjects: 118
Study 23590801 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequelae
Number of subjects: 118
Study 21837291 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement appliance (MAA) in neutral position (P2)
Number of subjects: 12
Study 21837291 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement appliance (MAA) in 50% advanced position (P4)
Number of subjects: 12
Study 21837291 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement appliance (MAA) in both positions
Number of subjects: 12
Study 19121573 — intervention group
Group type: EXPERIMENTAL
Intervention: guaifenesin 600 mg (G)
Number of subjects: 30
Study 19121573 — intervention group
Group type: EXPERIMENTAL
Intervention: benzonatate 200 mg (B)
Number of subjects: 30
Study 19121573 — intervention group
Group type: EXPERIMENTAL
Intervention: combination of benzonatate 200 mg and guaifenesin 600 mg (B+G)
Number of subjects: 30
Study 19121573 — intervention group
Group type: COMPARATOR
Intervention: placebo (P)
Number of subjects: 30
Study 16912719 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified head injury advice sheet
Number of subjects: 200
Study 16912719 — intervention group
Group type: COMPARATOR
Intervention: Standard head injury advice sheet
Number of subjects: 200
Study 15025743 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GFJ)
Number of subjects: 20
Study 15025743 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 20
Study 11124783 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilation tubes
Number of subjects: 187
Study 11124783 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 187
Study 9540874 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural somatostatin (single bolus injection)
Number of subjects: 160
Study 9540874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 8126502 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg entacapone
Number of subjects: 12
Study 8126502 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg levodopa/50 mg carbidopa with 200 mg entacapone
Number of subjects: 12
Study 8126502 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg levodopa/50 mg carbidopa with 800 mg entacapone
Number of subjects: 12
Study 8126502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2563190 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 67
Study 2563190 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 67
Study 1092513 — intervention group
Group type: EXPERIMENTAL
Intervention: Deanol (500 mg daily)
Number of subjects: 74
Study 1092513 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (40 mg daily)
Number of subjects: 74
Study 1092513 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 31163986 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg or 25 mg
Number of subjects: 706
Study 31163986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 706
Study 27652589 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel 20 mg single dose
Number of subjects: 43
Study 27652589 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel 30 mg single dose
Number of subjects: 43
Study 27652589 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel 20 mg loading dose followed by 5 mg/day maintenance dose
Number of subjects: 43
Study 27652589 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel 30 mg loading dose followed by 7.5 mg/day maintenance dose
Number of subjects: 43
Study 27652589 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg/day
Number of subjects: 43
Study 26598472 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality foster care intervention (n = 68)
Number of subjects: 95
Study 26598472 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual group (n = 68)
Number of subjects: 95
Study 26598472 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality foster care intervention
Number of subjects: 95
Study 24019134 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC) ablation
Number of subjects: 129
Study 24019134 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic surveillance
Number of subjects: 129
Study 21615670 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide 10 µg (subcutaneous) twice daily
Number of subjects: 86
Study 21615670 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin 100 mg (oral) daily
Number of subjects: 86
Study 19427432 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 8351
Study 19427432 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 20 to 40 mg/day
Number of subjects: 8351
Study 16951474 — intervention group
Group type: EXPERIMENTAL
Intervention: External hip protectors
Number of subjects: 0
Study 16951474 — intervention group
Group type: COMPARATOR
Intervention: Bisphosphonates
Number of subjects: 0
Study 15278032 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic transabdominal preperitoneal approach (TAPP)
Number of subjects: 121
Study 15278032 — intervention group
Group type: COMPARATOR
Intervention: Open mesh herniorrhaphy
Number of subjects: 121
Study 11753059 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive dorsiflexion exercise to the point of typical symptoms (CAECS subjects)
Number of subjects: 20
Study 11753059 — intervention group
Group type: COMPARATOR
Intervention: Repetitive dorsiflexion exercise to the point of fatigue (control subjects)
Number of subjects: 20
Study 11753059 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline and postexercise comparison of vibratory sensation
Number of subjects: 20
Study 9412550 — intervention group
Group type: COMPARATOR
Intervention: Budesonide (BUD) 800 micrograms/d
Number of subjects: 28
Study 9412550 — intervention group
Group type: COMPARATOR
Intervention: Budesonide (BUD) 1,600 micrograms/d
Number of subjects: 28
Study 9412550 — intervention group
Group type: COMPARATOR
Intervention: Budesonide (BUD) 3,200 micrograms/d
Number of subjects: 28
Study 9412550 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 750 micrograms/d
Number of subjects: 28
Study 9412550 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 1,500 micrograms/d
Number of subjects: 28
Study 9412550 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 2,000 micrograms/d
Number of subjects: 28
Study 7907097 — intervention group
Group type: EXPERIMENTAL
Intervention: ipsapirone (10.0 to 30.0 mg daily)
Number of subjects: 317
Study 7907097 — intervention group
Group type: COMPARATOR
Intervention: lorazepam (2.0 to 6.0 mg daily)
Number of subjects: 317
Study 7907097 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 317
Study 2959901 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (FNT)
Number of subjects: 28
Study 2959901 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IB)
Number of subjects: 28
Study 2959901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 31399793 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal ART offer
Number of subjects: 100
Study 28478185 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine liposome injectable suspension (80cc plus 1.3% liposomal bupivacaine 20cc; total injection 100cc)
Number of subjects: 96
Study 28478185 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine (periarticular injection of ropivacaine, ketorolac, morphine, and epinephrine in saline; 100cc)
Number of subjects: 96
Study 24594853 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Training Program (PTP) for 6 weeks
Number of subjects: 20
Study 24594853 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Training Program (PTP) for 12 weeks
Number of subjects: 20
Study 24594853 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline to 6 weeks delta
Number of subjects: 20
Study 23512759 — intervention group
Group type: EXPERIMENTAL
Intervention: Trophic feeding
Number of subjects: 525
Study 23512759 — intervention group
Group type: COMPARATOR
Intervention: Full feeding
Number of subjects: 525
Study 21696635 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA‐rich fish oil supplement (1060 mg EPA plus 274 mg DHA)
Number of subjects: 126
Study 21696635 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA‐rich fish oil supplement (900 mg DHA plus 180 mg EPA)
Number of subjects: 126
Study 21696635 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 19728632 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral sagittal split osteotomies (BSSO)
Number of subjects: 0
Study 19728632 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular distraction osteogenesis (MDO)
Number of subjects: 0
Study 16805356 — intervention group
Group type: EXPERIMENTAL
Intervention: Porter/Brown nasal hood
Number of subjects: 30
Study 16805356 — intervention group
Group type: COMPARATOR
Intervention: Accutron nasal hood
Number of subjects: 30
Study 16805356 — intervention group
Group type: EXPERIMENTAL
Intervention: Porter/Brown nasal hood with reduced suction
Number of subjects: 30
Study 16805356 — intervention group
Group type: COMPARATOR
Intervention: Accutron nasal hood with reduced suction
Number of subjects: 30
Study 12504644 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 220
Study 12504644 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 10923757 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.075 mg/kg)
Number of subjects: 15
Study 10923757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9275372 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended parietal cell vagotomy (EPCV)
Number of subjects: 36
Study 9275372 — intervention group
Group type: COMPARATOR
Intervention: Subtotal gastrectomy (SG)
Number of subjects: 36
Study 9275372 — intervention group
Group type: EXPERIMENTAL
Intervention: EPCV
Number of subjects: 36
Study 9275372 — intervention group
Group type: COMPARATOR
Intervention: SG
Number of subjects: 36
Study 9275372 — intervention group
Group type: EXPERIMENTAL
Intervention: EPCV and SG
Number of subjects: 36
Study 1675650 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% chlorhexidine detergent solution (Group A)
Number of subjects: 115
Study 1675650 — intervention group
Group type: COMPARATOR
Intervention: Placebo detergent (Group B)
Number of subjects: 115
Study 7093110 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg aspirin
Number of subjects: 12
Study 7093110 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg aspirin
Number of subjects: 12
Study 7093110 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30552505 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.4 g day−1 of sustained-release beta-alanine (CarnoSyn™, NAI, USA)
Number of subjects: 25
Study 30552505 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 25
Study 31089253 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame oil enriched with vitamin E (30 ml/day and 400 mg/day)
Number of subjects: 75
Study 31089253 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame oil (30 ml/day)
Number of subjects: 75
Study 31089253 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil (30 ml/day)
Number of subjects: 75
Study 30359215 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive preventive counseling with focus on diet modification followed by remote counseling by phone every two weeks for 3 months (total of 6 sessions).
Number of subjects: 100
Study 30359215 — intervention group
Group type: COMPARATOR
Intervention: Usual care in Health centers including basic preventive counseling.
Number of subjects: 100
Study 27865620 — intervention group
Group type: EXPERIMENTAL
Intervention: Chokeberry juice (300 mL/d)
Number of subjects: 38
Study 24518194 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise training in combination with conventional management (EX, n = 20)
Number of subjects: 40
Study 24518194 — intervention group
Group type: COMPARATOR
Intervention: Conventional management alone (CON, n = 20)
Number of subjects: 40
Study 22206079 — intervention group
Group type: EXPERIMENTAL
Intervention: Tri-retinol 1.1% cream
Number of subjects: 34
Study 22206079 — intervention group
Group type: COMPARATOR
Intervention: Tretinoin 0.025% cream
Number of subjects: 34
Study 20565456 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg i.v. administration of CAT-354
Number of subjects: 30
Study 20565456 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg s.c. administration of CAT-354
Number of subjects: 30
Study 20565456 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg s.c. administration of CAT-354 (two 150 mg injections)
Number of subjects: 30
Study 17634488 — intervention group
Group type: EXPERIMENTAL
Intervention: 18FDG PET scan
Number of subjects: 116
Study 17634488 — intervention group
Group type: COMPARATOR
Intervention: Surveillance program for PET-negative patients
Number of subjects: 116
Study 11235707 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG with cardiopulmonary bypass (CPB)
Number of subjects: 22
Study 11235707 — intervention group
Group type: COMPARATOR
Intervention: CABG without cardiopulmonary bypass (CPB)
Number of subjects: 22
Study 9279180 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised frusemide (1 mg/kg/body weight)
Number of subjects: 19
Study 9279180 — intervention group
Group type: COMPARATOR
Intervention: Intravenous frusemide (1 mg/kg/body weight)
Number of subjects: 19